BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37908143)

  • 1. Autophagy dysregulation plays a crucial role in regulatory T-cell loss and neuroinflammation in amyotrophic lateral sclerosis (ALS).
    Azad A; Gökmen ÜR; Uysal H; Köksoy S; Bilge U; Manguoğlu AE
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):336-344. PubMed ID: 37908143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.
    Sheean RK; McKay FC; Cretney E; Bye CR; Perera ND; Tomas D; Weston RA; Scheller KJ; Djouma E; Menon P; Schibeci SD; Marmash N; Yerbury JJ; Nutt SL; Booth DR; Stewart GJ; Kiernan MC; Vucic S; Turner BJ
    JAMA Neurol; 2018 Jun; 75(6):681-689. PubMed ID: 29507931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity.
    Beers DR; Zhao W; Wang J; Zhang X; Wen S; Neal D; Thonhoff JR; Alsuliman AS; Shpall EJ; Rezvani K; Appel SH
    JCI Insight; 2017 Mar; 2(5):e89530. PubMed ID: 28289705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis.
    Rashid Chehreh Bargh S; Tafakhori A; Masoumi F; Rahmani F; Ahmadi M; Namdar A; Azimi M; Tavasolian P; Habibi S; Zamani B; Maserrat M; Sadr M; Noorbakhsh F; Rezaei N
    Ir J Med Sci; 2018 Nov; 187(4):1065-1071. PubMed ID: 29574662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of regulatory T cells in amyotrophic lateral sclerosis and their therapeutic potential.
    Giovannelli I; Heath P; Shaw PJ; Kirby J
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Aug; 21(5-6):435-444. PubMed ID: 32484719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of FoxP3 Pre-mRNA Alternative Splicing to Enhance the Suppressive Activity of Regulatory T Cells from Amyotrophic Lateral Sclerosis Patients.
    Zhdanov DD; Gladilina YA; Blinova VG; Abramova AA; Shishparenok AN; Eliseeva DD
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38790984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival.
    Henkel JS; Beers DR; Wen S; Rivera AL; Toennis KM; Appel JE; Zhao W; Moore DH; Powell SZ; Appel SH
    EMBO Mol Med; 2013 Jan; 5(1):64-79. PubMed ID: 23143995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy.
    Alsuliman A; Appel SH; Beers DR; Basar R; Shaim H; Kaur I; Zulovich J; Yvon E; Muftuoglu M; Imahashi N; Kondo K; Liu E; Shpall EJ; Rezvani K
    Cytotherapy; 2016 Oct; 18(10):1312-24. PubMed ID: 27497700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alternation of autophagy/apoptosis in CD4+CD25+Foxp3+ Tregs on the developmental stages of atherosclerosis.
    Tian Y; Liang X; Wu Y
    Biomed Pharmacother; 2018 Jan; 97():1053-1060. PubMed ID: 29136784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children.
    Horellou P; de Chalus A; Giorgi L; Leroy C; Chrétien P; Hacein-Bey-Abina S; Bourgeois C; Mariette X; Serguera C; Le Grand R; Deiva K
    Front Immunol; 2021; 12():679770. PubMed ID: 34220827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the immune system in amyotrophic lateral sclerosis. Analysis of the natural killer cells and other circulating lymphocytes in a cohort of ALS patients.
    Piccoli T; Castro F; La Bella V; Meraviglia S; Di Simone M; Salemi G; Dieli F; Spataro R
    BMC Neurol; 2023 Jun; 23(1):222. PubMed ID: 37296379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Beclin-1, an autophagy-related protein, is associated with tumoral FOXP3 expression and Tregs in gastric adenocarcinoma: The function of Beclin-1 expression as a favorable prognostic factor in gastric adenocarcinoma.
    Song MJ; Park S; Won KY
    Pathol Res Pract; 2020 May; 216(5):152927. PubMed ID: 32204925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rab Geranylgeranyltransferase Subunit Beta as a Potential Indicator to Assess the Progression of Amyotrophic Lateral Sclerosis.
    Yang J; Xin C; Huo J; Li X; Dong H; Liu Q; Li R; Liu Y
    Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senescent-like Blood Lymphocytes and Disease Progression in Amyotrophic Lateral Sclerosis.
    Yildiz O; Schroth J; Tree T; Turner MR; Shaw PJ; Henson SM; Malaspina A
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36323511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial.
    Camu W; Mickunas M; Veyrune JL; Payan C; Garlanda C; Locati M; Juntas-Morales R; Pageot N; Malaspina A; Andreasson U; Kirby J; Suehs C; Saker S; Masseguin C; De Vos J; Zetterberg H; Shaw PJ; Al-Chalabi A; Leigh PN; Tree T; Bensimon G
    EBioMedicine; 2020 Sep; 59():102844. PubMed ID: 32651161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.
    Zewdie M; Howe R; Hoff ST; Doherty TM; Getachew N; Tarekegne A; Tessema B; Yamuah L; Aseffa A; Abebe M
    Tuberculosis (Edinb); 2016 Sep; 100():61-68. PubMed ID: 27553411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and activation of CD4+CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy.
    Stelmaszczyk-Emmel A; Zawadzka-Krajewska A; Szypowska A; Kulus M; Demkow U
    Int Arch Allergy Immunol; 2013; 162(1):16-24. PubMed ID: 23817221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms.
    Zhao W; Beers DR; Liao B; Henkel JS; Appel SH
    Neurobiol Dis; 2012 Dec; 48(3):418-28. PubMed ID: 22820142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.